LO-ZUMANDIMINE Drug Patent Profile
Which patents cover Lo-zumandimine, and when can generic versions of Lo-zumandimine launch?
Lo-zumandimine is a drug marketed by Aurobindo Pharma Ltd and is included in one NDA.
The generic ingredient in LO-ZUMANDIMINE is drospirenone; ethinyl estradiol. There is one drug master file entry for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lo-zumandimine
A generic version of LO-ZUMANDIMINE was approved as drospirenone; ethinyl estradiol by DR REDDYS LABS SA on September 7th, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LO-ZUMANDIMINE?
- What are the global sales for LO-ZUMANDIMINE?
- What is Average Wholesale Price for LO-ZUMANDIMINE?
Summary for LO-ZUMANDIMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Patent Applications: | 266 |
| Drug Prices: | Drug price information for LO-ZUMANDIMINE |
| DailyMed Link: | LO-ZUMANDIMINE at DailyMed |
US Patents and Regulatory Information for LO-ZUMANDIMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | LO-ZUMANDIMINE | drospirenone; ethinyl estradiol | TABLET;ORAL | 209632-001 | Feb 27, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
